Boston Scientific Pre-Tax Profit Margin 2012-2025 | BSX
Current and historical pre-tax profit margin for Boston Scientific (BSX) from 2012 to 2025. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Boston Scientific pre-tax profit margin for the three months ending September 30, 2025 was .
| Boston Scientific Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2025-09-30 | $19.35B | $3.27B | 16.90% |
| 2025-06-30 | $18.50B | $3.00B | 16.22% |
| 2025-03-31 | $17.55B | $2.48B | 14.12% |
| 2024-12-31 | $16.75B | $2.28B | 13.63% |
| 2024-09-30 | $15.91B | $2.20B | 13.84% |
| 2024-06-30 | $15.23B | $2.14B | 14.07% |
| 2024-03-31 | $14.71B | $2.15B | 14.61% |
| 2023-12-31 | $14.24B | $1.99B | 13.94% |
| 2023-09-30 | $13.76B | $1.88B | 13.63% |
| 2023-06-30 | $13.40B | $1.51B | 11.27% |
| 2023-03-31 | $13.05B | $1.43B | 10.95% |
| 2022-12-31 | $12.68B | $1.14B | 9.00% |
| 2022-09-30 | $12.57B | $0.87B | 6.88% |
| 2022-06-30 | $12.33B | $1.10B | 8.95% |
| 2022-03-31 | $12.16B | $0.91B | 7.46% |
| 2021-12-31 | $11.89B | $1.08B | 9.05% |
| 2021-09-30 | $11.47B | $1.26B | 11.02% |
| 2021-06-30 | $11.20B | $0.55B | 4.95% |
| 2021-03-31 | $10.12B | $0.22B | 2.21% |
| 2020-12-31 | $9.91B | $-0.08B | -0.80% |
| 2020-09-30 | $10.11B | $-0.39B | -3.88% |
| 2020-06-30 | $10.16B | $-0.07B | -0.73% |
| 2020-03-31 | $10.79B | $0.25B | 2.34% |
| 2019-12-31 | $10.74B | $0.69B | 6.40% |
| 2019-09-30 | $10.39B | $0.99B | 9.52% |
| 2019-06-30 | $10.08B | $1.35B | 13.44% |
| 2019-03-31 | $9.94B | $1.56B | 15.66% |
| 2018-12-31 | $9.82B | $1.42B | 14.48% |
| 2018-09-30 | $9.67B | $1.35B | 14.00% |
| 2018-06-30 | $9.50B | $1.21B | 12.71% |
| 2018-03-31 | $9.27B | $0.95B | 10.26% |
| 2017-12-31 | $9.05B | $0.93B | 10.31% |
| 2017-09-30 | $8.83B | $0.79B | 8.99% |
| 2017-06-30 | $8.71B | $0.74B | 8.52% |
| 2017-03-31 | $8.58B | $0.25B | 2.96% |
| 2016-12-31 | $8.39B | $0.18B | 2.11% |
| 2016-09-30 | $8.17B | $-0.25B | -3.05% |
| 2016-06-30 | $7.96B | $-0.87B | -10.97% |
| 2016-03-31 | $7.67B | $-0.37B | -4.84% |
| 2015-12-31 | $7.48B | $-0.65B | -8.69% |
| 2015-09-30 | $7.39B | $-0.87B | -11.74% |
| 2015-06-30 | $7.34B | $-0.50B | -6.77% |
| 2015-03-31 | $7.37B | $-0.71B | -9.57% |
| 2014-12-31 | $7.38B | $-0.51B | -6.90% |
| 2014-09-30 | $7.33B | $0.10B | 1.42% |
| 2014-06-30 | $7.22B | $0.06B | 0.84% |
| 2014-03-31 | $7.16B | $0.32B | 4.43% |
| 2013-12-31 | $7.14B | $-0.22B | -3.12% |
| 2013-09-30 | $7.13B | $-0.23B | -3.24% |
| 2013-06-30 | $7.13B | $-0.85B | -11.99% |
| 2013-03-31 | $7.14B | $-4.62B | -64.73% |
| 2012-12-31 | $7.25B | $-4.11B | -56.66% |
| 2012-09-30 | $7.28B | $-4.06B | -55.76% |
| 2012-06-30 | $7.42B | $-3.28B | -44.28% |
| 2012-03-31 | $7.56B | $0.49B | 6.51% |
| 2011-12-31 | $7.62B | $0.64B | 8.42% |
| 2011-09-30 | $7.78B | $0.77B | 9.93% |
| 2011-06-30 | $7.82B | $0.82B | 10.54% |
| 2011-03-31 | $7.77B | $0.79B | 10.10% |
| 2010-12-31 | $7.81B | $-1.06B | -13.62% |
| 2010-09-30 | $7.88B | $-2.64B | -33.49% |
| 2010-06-30 | $7.99B | $-2.85B | -35.62% |
| 2010-03-31 | $8.14B | $-2.79B | -34.23% |
| 2009-12-31 | $8.19B | $-1.31B | -15.97% |
| 2009-09-30 | $8.11B | $-2.49B | -30.65% |
| 2009-06-30 | $8.06B | $-2.51B | -31.13% |
| 2009-03-31 | $8.01B | $-2.59B | -32.32% |
| 2008-12-31 | $8.05B | $-2.03B | -25.23% |
| 2008-09-30 | $8.20B | $-0.10B | -1.23% |
| 2008-06-30 | $8.27B | $-0.29B | -3.53% |
| 2008-03-31 | $8.32B | $-0.27B | -3.20% |
| 2007-12-31 | $8.36B | $-0.57B | -6.81% |
| 2007-09-30 | $8.27B | $0.20B | 2.36% |
| 2007-06-30 | $8.25B | $0.51B | 6.12% |
| 2007-03-31 | $8.29B | $-3.81B | -45.94% |
| 2006-12-31 | $7.82B | $-3.54B | -45.20% |
| 2006-09-30 | $7.30B | $-3.27B | -44.76% |
| 2006-06-30 | $6.78B | $-3.67B | -54.11% |
| 2006-03-31 | $6.29B | $0.83B | 13.17% |
| 2005-12-31 | $6.28B | $0.89B | 14.18% |
| 2005-09-30 | $6.34B | $0.91B | 14.38% |
| 2005-06-30 | $6.31B | $1.61B | 25.53% |
| 2005-03-31 | $6.16B | $1.73B | 28.15% |
| 2004-12-31 | $5.62B | $1.49B | 26.56% |
| 2004-09-30 | $4.96B | $1.22B | 24.56% |
| 2004-06-30 | $4.36B | $1.03B | 23.62% |
| 2004-03-31 | $3.75B | $0.76B | 20.21% |
| 2003-12-31 | $3.48B | $0.64B | 18.50% |
| 2003-09-30 | $3.35B | $0.60B | 17.96% |
| 2003-06-30 | $3.20B | $0.68B | 21.24% |
| 2003-03-31 | $3.05B | $0.57B | 18.75% |
| 2002-12-31 | $2.92B | $0.55B | 18.81% |
| 2002-09-30 | $2.78B | $0.50B | 18.04% |
| 2002-06-30 | $2.73B | $0.35B | 12.97% |
| 2002-03-31 | $2.69B | $0.13B | 4.97% |
| 2001-12-31 | $2.67B | $0.04B | 1.65% |
| 2001-09-30 | $2.63B | $0.03B | 1.14% |
| 2001-06-30 | $2.62B | $0.06B | 2.37% |
| 2001-03-31 | $2.64B | $0.40B | 15.08% |
| 2000-12-31 | $2.66B | $0.53B | 19.78% |
| 2000-09-30 | $2.74B | $0.61B | 22.13% |
| 2000-06-30 | $2.78B | $0.57B | 20.56% |
| 2000-03-31 | $2.81B | $0.57B | 20.16% |
| 1999-12-31 | $2.84B | $0.56B | 19.77% |
| 1999-09-30 | $2.84B | $0.55B | 19.32% |
| 1999-06-30 | $2.73B | $-0.18B | -6.64% |
| 1999-03-31 | $2.49B | $-0.22B | -8.92% |
| 1998-12-31 | $2.23B | $-0.28B | -12.32% |
| 1998-09-30 | $2.00B | $-0.38B | -18.89% |
| 1998-06-30 | $1.88B | $0.40B | 20.98% |
| 1998-03-31 | $1.86B | $0.25B | 13.35% |
| 1997-12-31 | $1.83B | $0.26B | 14.09% |
| 1997-09-30 | $1.76B | $0.33B | 18.47% |
| 1997-06-30 | $1.67B | $0.30B | 18.06% |
| 1997-03-31 | $1.57B | $0.37B | 23.82% |
| 1996-12-31 | $1.46B | $0.30B | 20.38% |
| 1996-09-30 | $1.35B | $0.18B | 13.09% |
| 1996-06-30 | $1.26B | $0.15B | 11.66% |
| 1996-03-31 | $1.13B | $0.17B | 15.12% |
| 1995-12-31 | $1.03B | $0.09B | 8.39% |
| 1995-09-30 | $0.85B | $0.13B | 15.45% |
| 1995-06-30 | $0.68B | $0.09B | 13.29% |
| 1995-03-31 | $0.63B | $0.05B | 7.68% |
| 1994-12-31 | $0.58B | $0.13B | 22.13% |
| 1994-09-30 | $0.56B | $0.12B | 21.89% |
| 1994-06-30 | $0.55B | $0.12B | 21.61% |
| 1994-03-31 | $0.47B | $0.12B | 24.73% |
| 1993-12-31 | $0.38B | $0.11B | 28.95% |
| 1993-09-30 | $0.36B | $0.16B | 44.63% |
| 1993-06-30 | $0.35B | $0.16B | 45.85% |
| 1993-03-31 | $0.33B | $0.15B | 46.53% |
| 1992-12-31 | $0.32B | $0.20B | 64.44% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $109.879B | $20.074B |
| Boston Scientific Corporation manufactures medical devices and products used in various interventional medical specialties worldwide. The company has adopted the organic as well as inorganic routes for success. Boston Scientific currently has 3 global reportable segments - Cardiovascular, Rhythm and Neuro and MedSurg. While Cardiovascular includes Interventional Cardiology and Peripheral Interventions, Rhythm and Neuro comprises Cardiac Rhythm Management, Electrophysiology and Neuromodulation. The MedSurg group comprises 2 sub segments, viz. Endoscopy, Urology and Pelvic Health. Boston Scientific markets a broad portfolio of internally-developed and self-manufactured drug eluting stents including the Promus PREMIER, Promus Element and Promus Element Plus everolimus-eluting stents. Within the CRM segment, the company deals with implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $193.137B | 21.57 |
| EssilorLuxottica (ESLOY) | France | $140.784B | 0.00 |
| Stryker (SYK) | United States | $136.173B | 26.12 |
| Medtronic (MDT) | Ireland | $130.317B | 18.06 |
| Medline (MDLN) | United States | $62.231B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $47.151B | 0.00 |
| ResMed (RMD) | United States | $40.201B | 26.84 |
| Agilent Technologies (A) | United States | $36.062B | 22.85 |
| GE HealthCare Technologies (GEHC) | United States | $36.041B | 17.27 |
| Koninklijke Philips (PHG) | Netherlands | $28.522B | 18.63 |
| Terumo (TRUMY) | Japan | $19.692B | 22.25 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.783B | 11.09 |
| Insulet (PODD) | United States | $17.275B | 53.62 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.896B | 0.00 |
| Baxter (BAX) | United States | $11.170B | 9.02 |
| Sunny Optical Technology (SNPTF) | China | $8.485B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.955B | 28.60 |
| Demant (WILYY) | Denmark | $6.521B | 0.00 |
| Envista Holdings (NVST) | United States | $4.828B | 24.47 |
| Lantheus Holdings (LNTH) | United States | $4.324B | 13.17 |
| BillionToOne (BLLN) | United States | $4.229B | 0.00 |
| ICU Medical (ICUI) | United States | $3.749B | 23.80 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.263B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.092B | 14.59 |
| Haemonetics (HAE) | United States | $2.681B | 11.73 |
| Neogen (NEOG) | United States | $2.308B | 50.52 |
| Phibro Animal Health (PAHC) | United States | $2.102B | 18.52 |
| QuidelOrtho (QDEL) | United States | $1.988B | 12.78 |
| Perrigo (PRGO) | Ireland | $1.971B | 4.94 |
| LeMaitre Vascular (LMAT) | United States | $1.963B | 39.52 |
| AtriCure (ATRC) | United States | $1.836B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.672B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.564B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.452B | 63.64 |
| AdaptHealth (AHCO) | United States | $1.452B | 21.02 |
| Capricor Therapeutics (CAPR) | United States | $1.152B | 0.00 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.092B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.090B | 323.29 |
| InMode (INMD) | Israel | $0.956B | 10.80 |
| Tilray Brands (TLRY) | Canada | $0.897B | 0.00 |
| Valneva SE (VALN) | France | $0.833B | 0.00 |
| Omeros (OMER) | United States | $0.801B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.795B | 0.00 |
| CeriBell (CBLL) | United States | $0.775B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.589B | 15.95 |
| Verano Holdings (VRNO) | United States | $0.469B | 0.00 |
| Brainsway (BWAY) | Israel | $0.442B | 75.20 |
| Cerus (CERS) | United States | $0.419B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.402B | 0.00 |
| SNDL (SNDL) | Canada | $0.389B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.387B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.321B | 25.61 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| Quanterix (QTRX) | United States | $0.288B | 0.00 |
| Evolus (EOLS) | United States | $0.275B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.226B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.220B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Organigram Global (OGI) | Canada | $0.215B | 0.00 |
| High Tide (HITI) | Canada | $0.213B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.206B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.203B | 59.83 |
| OraSure Technologies (OSUR) | United States | $0.202B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.200B | 17.93 |
| Accendra Health (ACH) | United States | $0.185B | 1.85 |
| Sanara MedTech (SMTI) | United States | $0.177B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.163B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Apyx Medical (APYX) | United States | $0.156B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.143B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.137B | 0.00 |
| Fonar (FONR) | United States | $0.116B | 16.86 |
| MacroGenics (MGNX) | United States | $0.114B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.103B | 0.00 |
| Biote (BTMD) | United States | $0.100B | 4.40 |
| Exagen (XGN) | United States | $0.076B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 25.54 |
| Sharps Technology (STSS) | United States | $0.051B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 30.92 |
| Rockwell Medical (RMTI) | United States | $0.043B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.042B | 0.00 |
| Veru (VERU) | United States | $0.038B | 0.00 |
| Modular Medical (MODD) | United States | $0.033B | 0.00 |
| United-Guardian (UG) | United States | $0.032B | 16.30 |
| Jin Medical (ZJYL) | China | $0.022B | 0.00 |
| Bonk (BNKK) | United States | $0.020B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.013B | 0.00 |
| INLIF (INLF) | China | $0.009B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |